0001193125-24-065471.txt : 20240312 0001193125-24-065471.hdr.sgml : 20240312 20240312090053 ACCESSION NUMBER: 0001193125-24-065471 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240311 ITEM INFORMATION: Other Events FILED AS OF DATE: 20240312 DATE AS OF CHANGE: 20240312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 24740376 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 8-K 1 d759790d8k.htm 8-K 8-K
false 0001492674 0001492674 2024-03-11 2024-03-11

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 11, 2024

 

 

T2 BIOSYSTEMS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-36571   20-4827488

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification Number)

101 Hartwell Avenue, Lexington, Massachusetts 02421

(Address of principal executive offices, including Zip Code)

(781) 761-4646

(Registrant’s telephone number, including area code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Common stock, par value $0.001 per share   TTOO   The Nasdaq Stock Market LLC
    (The Nasdaq Capital Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 8.01

Other Events

On March 11, 2024, the Company received notice from the Nasdaq Hearings Panel that it has granted the Company’s request for continued listing on the Nasdaq Stock Market, subject to the Company demonstrating compliance with Nasdaq’s market value of listed securities (“Market Value”) requirement, as set forth in Nasdaq Listing Rule 5550(b)(2) (the “Rule”) on or before May 20, 2024.

As previously reported, on November 20, 2023, the Nasdaq Listing Qualifications Staff (the “Staff”) notified the Company that it failed to satisfy the minimum $35 million Market Value threshold for the previous 30 consecutive business days and, as a result, no longer satisfied the requirements of the Rule. In accordance with the terms of the Mandatory Panel Monitor imposed on the Company by Nasdaq, Nasdaq did not grant the Company a grace period but rather issued a delist determination, which was stayed pending the Company’s appeal of the Staff’s delisting determination. On November 27, 2023, the Company requested a hearing, which was held on February 15, 2024.

The Rule requires that the Company maintain a closing Market Value of at least $35.0 million for a minimum of ten consecutive business days. There can be no assurance, however, that the Company will be able to timely comply with the terms of the Nasdaq Hearings Panel’s decision.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 12, 2024   T2 BIOSYSTEMS, INC.
    By:  

/s/ John Sprague

      John Sprague
      Chief Financial Officer
EX-101.SCH 2 ttoo-20240311.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 ttoo-20240311_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 ttoo-20240311_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document and Entity Information
Mar. 11, 2024
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001492674
Document Type 8-K
Document Period End Date Mar. 11, 2024
Entity Registrant Name T2 BIOSYSTEMS, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-36571
Entity Tax Identification Number 20-4827488
Entity Address, Address Line One 101 Hartwell Avenue
Entity Address, City or Town Lexington
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02421
City Area Code (781)
Local Phone Number 761-4646
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common stock, par value $0.001 per share
Trading Symbol TTOO
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d759790d8k.htm ttoo-20240311.xsd ttoo-20240311_lab.xml ttoo-20240311_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d759790d8k.htm": { "nsprefix": "ttoo", "nsuri": "http://www.t2biosystems.com/20240311", "dts": { "inline": { "local": [ "d759790d8k.htm" ] }, "schema": { "local": [ "ttoo-20240311.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd" ] }, "labelLink": { "local": [ "ttoo-20240311_lab.xml" ] }, "presentationLink": { "local": [ "ttoo-20240311_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "duration_2024-03-11_to_2024-03-11", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d759790d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "duration_2024-03-11_to_2024-03-11", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d759790d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.t2biosystems.com//20240311/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 14 0001193125-24-065471-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-24-065471-xbrl.zip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end
XML 15 d759790d8k_htm.xml IDEA: XBRL DOCUMENT 0001492674 2024-03-11 2024-03-11 false 0001492674 8-K 2024-03-11 T2 BIOSYSTEMS, INC. DE 001-36571 20-4827488 101 Hartwell Avenue Lexington MA 02421 (781) 761-4646 false false false false Common stock, par value $0.001 per share TTOO NASDAQ false